Reducing unnecessary referrals for colposcopy in hrHPV-positive women within the Dutch cervical cancer screening programme: A modelling study.

CONCLUSIONS: To reduce the number of unnecessary referrals without increasing incidence and mortality by more than 2% in the Dutch cervical cancer screening programme, genotyping for HPV16 or HPV16/18 should be implemented with 12 months to repeat testing. PMID: 33451725 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33451725?dopt=Abstract

Source: Gynecologic Oncology - January 12, 2021 Category: Cancer & Oncology Authors: Kaljouw S, Jansen EEL, Aitken CA, Harrijvan LM, Naber SK, de Kok IMCM Tags: Gynecol Oncol Source Type: research